258 related articles for article (PubMed ID: 18006819)
1. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
Kunizaki M; Hamamoto R; Silva FP; Yamaguchi K; Nagayasu T; Shibuya M; Nakamura Y; Furukawa Y
Cancer Res; 2007 Nov; 67(22):10759-65. PubMed ID: 18006819
[TBL] [Abstract][Full Text] [Related]
2. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
[TBL] [Abstract][Full Text] [Related]
3. Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells.
Silva FP; Hamamoto R; Kunizaki M; Tsuge M; Nakamura Y; Furukawa Y
Oncogene; 2008 Apr; 27(19):2686-92. PubMed ID: 17998933
[TBL] [Abstract][Full Text] [Related]
4. Enhanced SMYD3 expression is essential for the growth of breast cancer cells.
Hamamoto R; Silva FP; Tsuge M; Nishidate T; Katagiri T; Nakamura Y; Furukawa Y
Cancer Sci; 2006 Feb; 97(2):113-8. PubMed ID: 16441421
[TBL] [Abstract][Full Text] [Related]
5. Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells.
Luo XG; Zou JN; Wang SZ; Zhang TC; Xi T
IUBMB Life; 2010 Mar; 62(3):194-9. PubMed ID: 20039369
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
Zou JN; Wang SZ; Yang JS; Luo XG; Xie JH; Xi T
Cancer Lett; 2009 Jul; 280(1):78-85. PubMed ID: 19321255
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase.
Fu W; Liu N; Qiao Q; Wang M; Min J; Zhu B; Xu RM; Yang N
J Biol Chem; 2016 Apr; 291(17):9173-80. PubMed ID: 26929412
[TBL] [Abstract][Full Text] [Related]
8. Regulation of p53 activity through lysine methylation.
Chuikov S; Kurash JK; Wilson JR; Xiao B; Justin N; Ivanov GS; McKinney K; Tempst P; Prives C; Gamblin SJ; Barlev NA; Reinberg D
Nature; 2004 Nov; 432(7015):353-60. PubMed ID: 15525938
[TBL] [Abstract][Full Text] [Related]
9. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.
Hamamoto R; Furukawa Y; Morita M; Iimura Y; Silva FP; Li M; Yagyu R; Nakamura Y
Nat Cell Biol; 2004 Aug; 6(8):731-40. PubMed ID: 15235609
[TBL] [Abstract][Full Text] [Related]
10. Multiple lysine methylation of PCAF by Set9 methyltransferase.
Masatsugu T; Yamamoto K
Biochem Biophys Res Commun; 2009 Mar; 381(1):22-6. PubMed ID: 19351588
[TBL] [Abstract][Full Text] [Related]
11. SMYD3-NY, a novel SMYD3 mRNA transcript variant, may have a role in human spermatogenesis.
Zhou Z; Ren X; Huang X; Lu L; Xu M; Yin L; Li J; Sha J
Ann Clin Lab Sci; 2005; 35(3):270-7. PubMed ID: 16081583
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells.
Guo N; Chen R; Li Z; Liu Y; Cheng D; Zhou Q; Zhou J; Lin Q
Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):354-61. PubMed ID: 21450690
[TBL] [Abstract][Full Text] [Related]
13. SET and MYND domain-containing protein 3 decreases sensitivity to dexamethasone and stimulates cell adhesion and migration in NIH3T3 cells.
Luo XG; Ding Y; Zhou QF; Ye L; Wang SZ; Xi T
J Biosci Bioeng; 2007 May; 103(5):444-50. PubMed ID: 17609160
[TBL] [Abstract][Full Text] [Related]
14. Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins.
Rathert P; Dhayalan A; Ma H; Jeltsch A
Mol Biosyst; 2008 Dec; 4(12):1186-90. PubMed ID: 19396382
[TBL] [Abstract][Full Text] [Related]
15. RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation.
Hayakawa T; Ohtani Y; Hayakawa N; Shinmyozu K; Saito M; Ishikawa F; Nakayama J
Genes Cells; 2007 Jun; 12(6):811-26. PubMed ID: 17573780
[TBL] [Abstract][Full Text] [Related]
16. Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway.
Colón-Bolea P; Crespo P
Bioessays; 2014 Dec; 36(12):1162-9. PubMed ID: 25382779
[TBL] [Abstract][Full Text] [Related]
17. Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization.
Yoshioka Y; Suzuki T; Matsuo Y; Tsurita G; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
Cancer Med; 2017 Jul; 6(7):1665-1672. PubMed ID: 28639750
[TBL] [Abstract][Full Text] [Related]
18. SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1.
Yoshioka Y; Suzuki T; Matsuo Y; Nakakido M; Tsurita G; Simone C; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2016 Nov; 7(46):75023-75037. PubMed ID: 27626683
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the methylation site specificity of SET7/9.
Couture JF; Collazo E; Hauk G; Trievel RC
Nat Struct Mol Biol; 2006 Feb; 13(2):140-6. PubMed ID: 16415881
[TBL] [Abstract][Full Text] [Related]
20. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers.
Tsuge M; Hamamoto R; Silva FP; Ohnishi Y; Chayama K; Kamatani N; Furukawa Y; Nakamura Y
Nat Genet; 2005 Oct; 37(10):1104-7. PubMed ID: 16155568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]